Suggestions
Igor Puzanov
Judith and Stanford Lipsey Chair in Clinical Cancer Research at Roswell Park Comprehensive Cancer Center
Igor Puzanov is a prominent oncologist and researcher currently serving in several key roles at Roswell Park Comprehensive Cancer Center in Buffalo, New York.13 His positions include:
Professional Roles
- Senior Vice President of Clinical Investigation
- Professor of Oncology
- Director of the Center for Early Phase Clinical Trials
- The Judith and Stanford Lipsey Endowed Chair in Clinical Cancer Research
- Chief of the Early Phase Clinical Trials Division
- Chief of the Melanoma Section
Dr. Puzanov is also a Professor of Medicine at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo.13
Expertise and Research Focus
Dr. Puzanov specializes in:
- Early phase clinical trials and drug development
- Melanoma treatment
- Cancer immunotherapy and experimental therapeutics
- Precision medicine
His research focuses on developing novel cancer therapies, with an emphasis on combining immune and targeted agents. He has extensive experience in conducting clinical trials from pre-clinical phases through Phase III studies.23
Education and Training
- MD from Charles University, Prague, Czech Republic (1991)
- Master of Science in Clinical Investigation from Vanderbilt University (2007)
- Residency at UT Southwestern Medical Center at Dallas
- Fellowship at Vanderbilt University
Achievements
Dr. Puzanov has made significant contributions to the field of oncology:
- Instrumental in several FDA approvals of breakthrough anti-cancer drugs
- Published nearly 200 manuscripts, articles, and reviews in prestigious journals
- Highly cited researcher with over 49,000 citations4
His LinkedIn profile can be found under the username igor-puzanov-17099b18, confirming his affiliation with Roswell Park Comprehensive Cancer Center.5
